- Home
- AQMS vs GTBP Comparison
AQMS vs GTBP Comparison
Compare AQMS & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- GTBP
- Stock Information
- Founded
- AQMS 2014
- GTBP 1965
- Country
- AQMS United States
- GTBP United States
- Employees
- AQMS N/A
- GTBP N/A
- Industry
- AQMS Metal Fabrications
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- GTBP Health Care
- Exchange
- AQMS Nasdaq
- GTBP Nasdaq
- Market Cap
- AQMS 5.1M
- GTBP 5.5M
- IPO Year
- AQMS 2015
- GTBP N/A
- Fundamental
- Price
- AQMS $3.75
- GTBP $0.84
- Analyst Decision
- AQMS Buy
- GTBP Strong Buy
- Analyst Count
- AQMS 1
- GTBP 1
- Target Price
- AQMS $30.00
- GTBP $11.00
- AVG Volume (30 Days)
- AQMS 35.1K
- GTBP 292.5K
- Earning Date
- AQMS 08-13-2025
- GTBP 08-14-2025
- Dividend Yield
- AQMS N/A
- GTBP N/A
- EPS Growth
- AQMS N/A
- GTBP N/A
- EPS
- AQMS N/A
- GTBP N/A
- Revenue
- AQMS N/A
- GTBP N/A
- Revenue This Year
- AQMS N/A
- GTBP N/A
- Revenue Next Year
- AQMS $550.00
- GTBP N/A
- P/E Ratio
- AQMS N/A
- GTBP N/A
- Revenue Growth
- AQMS N/A
- GTBP N/A
- 52 Week Low
- AQMS $3.37
- GTBP $0.88
- 52 Week High
- AQMS $46.00
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- AQMS 44.14
- GTBP 23.64
- Support Level
- AQMS $3.55
- GTBP $0.88
- Resistance Level
- AQMS $4.35
- GTBP $0.99
- Average True Range (ATR)
- AQMS 0.31
- GTBP 0.10
- MACD
- AQMS 0.10
- GTBP 0.01
- Stochastic Oscillator
- AQMS 38.78
- GTBP 20.15
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.